upadacitinib
abbvie
['upadacitinib']
a higher dose of #upadacitinib decreased disease severity and induced clinical remission for a longer period among patients with active #uc, brian g. feagan, md, of , reported at #acg2022 #gitwitter #medtwitter 
The content you need, when you need it.